Correlation Between Genmab AS and Nordea Invest

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Nordea Invest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Nordea Invest into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Nordea Invest Basis, you can compare the effects of market volatilities on Genmab AS and Nordea Invest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Nordea Invest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Nordea Invest.

Diversification Opportunities for Genmab AS and Nordea Invest

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Genmab and Nordea is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Nordea Invest Basis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nordea Invest Basis and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Nordea Invest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nordea Invest Basis has no effect on the direction of Genmab AS i.e., Genmab AS and Nordea Invest go up and down completely randomly.

Pair Corralation between Genmab AS and Nordea Invest

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Nordea Invest. In addition to that, Genmab AS is 3.77 times more volatile than Nordea Invest Basis. It trades about -0.07 of its total potential returns per unit of risk. Nordea Invest Basis is currently generating about 0.18 per unit of volatility. If you would invest  17,345  in Nordea Invest Basis on September 19, 2024 and sell it today you would earn a total of  270.00  from holding Nordea Invest Basis or generate 1.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Nordea Invest Basis

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Nordea Invest Basis 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nordea Invest Basis are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Nordea Invest is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Genmab AS and Nordea Invest Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Nordea Invest

The main advantage of trading using opposite Genmab AS and Nordea Invest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Nordea Invest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nordea Invest will offset losses from the drop in Nordea Invest's long position.
The idea behind Genmab AS and Nordea Invest Basis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal